Lumos Pharma | NLNK - Market Capitalization


Lumos Pharma reported $21.8M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Pfizer USD 141.57B 6.48B Dec/2025
Prothena USD 514M 11M Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025